Privia Health Group (NASDAQ:PRVA) CEO Parth Mehrotra Sells 26,509 Shares

Privia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra sold 26,509 shares of the business’s stock in a transaction that occurred on Monday, March 16th. The shares were sold at an average price of $22.11, for a total value of $586,113.99. Following the transaction, the chief executive officer owned 555,443 shares of the company’s stock, valued at approximately $12,280,844.73. This trade represents a 4.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Parth Mehrotra also recently made the following trade(s):

• On Friday, March 13th, Parth Mehrotra sold 27,229 shares of Privia Health Group stock. The stock was sold at an average price of $21.52, for a total transaction of $585,968.08.
• On Thursday, March 12th, Parth Mehrotra sold 26,763 shares of Privia Health Group stock. The stock was sold at an average price of $21.90, for a total transaction of $586,109.70.
• On Tuesday, March 10th, Parth Mehrotra sold 21,097 shares of Privia Health Group stock. The shares were sold at an average price of $22.71, for a total transaction of $479,112.87.
• On Monday, March 9th, Parth Mehrotra sold 41,999 shares of Privia Health Group stock. The stock was sold at an average price of $22.86, for a total transaction of $960,097.14.
• On Friday, March 6th, Parth Mehrotra sold 21,440 shares of Privia Health Group stock. The stock was sold at an average price of $23.15, for a total transaction of $496,336.00.

Privia Health Group Price Performance

Shares of PRVA stock opened at $21.59 on Thursday. Privia Health Group, Inc. has a one year low of $18.77 and a one year high of $26.51. The company’s fifty day moving average price is $22.75 and its 200-day moving average price is $23.60. The company has a market capitalization of $2.67 billion, a price-to-earnings ratio of 127.00, a PEG ratio of 1.39 and a beta of 0.82.

Privia Health Group (NASDAQ:PRVA) last issued its earnings results on Thursday, February 26th. The company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.21. The company had revenue of $541.17 million during the quarter, compared to the consensus estimate of $516.61 million. Privia Health Group had a net margin of 1.08% and a return on equity of 3.06%. Privia Health Group’s quarterly revenue was up 17.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.21 EPS. Equities research analysts expect that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts recently issued reports on PRVA shares. Jefferies Financial Group reissued a “buy” rating and set a $32.00 target price on shares of Privia Health Group in a research note on Thursday, February 26th. Wolfe Research set a $31.00 price target on Privia Health Group in a research note on Tuesday, January 6th. Citigroup cut their price objective on shares of Privia Health Group from $34.00 to $32.00 and set a “buy” rating for the company in a report on Tuesday, March 3rd. Truist Financial lifted their price objective on shares of Privia Health Group from $31.00 to $33.00 and gave the company a “buy” rating in a research report on Monday, March 2nd. Finally, Royal Bank Of Canada started coverage on shares of Privia Health Group in a report on Friday, January 9th. They issued an “outperform” rating and a $31.00 target price on the stock. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Privia Health Group presently has an average rating of “Moderate Buy” and a consensus target price of $31.00.

Institutional Trading of Privia Health Group

Several hedge funds have recently modified their holdings of the company. Bayban bought a new stake in Privia Health Group in the fourth quarter worth $26,000. Invesco Ltd. lifted its position in Privia Health Group by 5.1% during the fourth quarter. Invesco Ltd. now owns 427,615 shares of the company’s stock valued at $10,139,000 after purchasing an additional 20,652 shares during the last quarter. Wellington Management Group LLP grew its stake in shares of Privia Health Group by 3.8% in the 4th quarter. Wellington Management Group LLP now owns 233,446 shares of the company’s stock worth $5,535,000 after buying an additional 8,531 shares in the last quarter. Millennium Management LLC increased its holdings in shares of Privia Health Group by 19.0% in the 4th quarter. Millennium Management LLC now owns 702,744 shares of the company’s stock worth $16,662,000 after buying an additional 112,428 shares during the last quarter. Finally, Gotham Asset Management LLC increased its holdings in shares of Privia Health Group by 22.4% in the 4th quarter. Gotham Asset Management LLC now owns 36,995 shares of the company’s stock worth $877,000 after buying an additional 6,773 shares during the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.